NFE2L2 and amyotrophic lateral sclerosis: Such knowledge will be essential for the design of targeted interventions that fine-tune astrocytic Nrf2 activity, balance glial responses, and ultimately contribute to slowing disease progression and improving quality of life for people living with ALS [71].